RECK antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
RECK antibody
category
Primary Antibodies
provider
FineTest
reference
FNab10074
tested applications
ELISA, IHC

Description

Negatively regulates matrix metalloproteinase-9(MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
reversion-inducing-cysteine-rich protein with kazal motifs (RECK)
Host
Rabbit
Reactivity
Human
Recommended Dilution
IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
110 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
O95980
Gene ID
8434
Alias
Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK),Suppressor of tumorigenicity 15 protein,RECK,ST15
Background
Antibody anti-RECK
Status
RUO
Note
Mol. Weight 110 kDa

Descripción

Related Products

EH2262

Human RECK (Reversion-inducing cysteine-rich protein with Kazal motifs) ELISA Kit

Ver Producto
FNab07224

RECK antibody

Negatively regulates matrix metalloproteinase-9(MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Ver Producto
FNab10074

RECK antibody

Negatively regulates matrix metalloproteinase-9(MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.

Ver Producto